Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of…
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of…
CARSON CITY, Nev., Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company…
ROCKAWAY, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is…
Additions of ProgenaMatrix® and revyve™ Antimicrobial Wound Gel part of planned expansion of BioStem’s commercial product portfolioPOMPANO BEACH, Fla., Nov.…
SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”…
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for…
Pharma and health care industries take deliberate steps, not leaps, toward AI innovation and digital transformation CARY, N.C., Nov. 19,…
Fresenius Medical Care's application of the Anemia Control Model recognized as one of only six projects chosen from over 300…
Better People Podcast featured Sales Focus Inc. Founder and CEO Tony Horwath on the Better People Podcast hosted by MidAtlantic…